Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 3/20 | 0.85 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.85 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.85 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.85 |
| ▸ | FAAH | O00519 | 3/20 | 0.82 |
| ▸ | CNR1 | P21554 | 2/20 | 0.82 |
| ▸ | CNR2 | P34972 | 2/20 | 0.82 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.82 |
| ▸ | MAPT | P10636 | 1/20 | 0.82 |
| ▸ | HPGD | P15428 | 1/20 | 0.82 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.69 |
| ▸ | SELP | P16109 | 1/20 | 0.65 |
| ▸ | MGLL | Q99685 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30864682 | 1.00 | PRKCA (0.85) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL8470069 | 1.00 | PRKCA (0.85) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL8049295 | 1.00 | PRKCA (0.85) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL8385633 | 0.99 | PRKCA (0.88) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL8385636 | 0.99 | PRKCA (0.88) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL8385580 | 0.97 | PRKCA (0.90) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL6269494 | 0.97 | PRKCA (0.90) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL21625281 | 0.97 | PRKCA (0.90) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL1009384 | 0.97 | PRKCA (0.90) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL31228870 | 0.97 | PRKCA (0.90) | PRKCAPRKCEPRKCQPRKCDFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025129333-A1 | LIPID NANOPARTICLES HAVING NON-POLAR LIPIDS FOR NUCLEIC ACID DELIVERY TO THE LIVER | NANOVATION THERAPEUTICS INC. (CA) | 2025-06-26 | — | — | WO | claimed |
| EP-0995430-A2 | Use of diacylolycerols for enhancing the barrier function of the skin | Beiersdorf Aktiengesellschaft (DE) | 2000-04-26 | — | — | EP | claimed |
| EP-0655907-B1 | USE OF DIACYLOLYCEROLS FOR INCREASING THE MELANIN CONTENT IN MELANOCYTES | UNIV BOSTON (US) | 1999-04-28 | — | — | EP | claimed |
| WO-2025129333-A1 | LIPID NANOPARTICLES HAVING NON-POLAR LIPIDS FOR NUCLEIC ACID DELIVERY TO THE LIVER | NANOVATION THERAPEUTICS INC. (CA) | 2025-06-26 | — | — | WO | disclosed |
| CN-116669705-A | Pharmaceutical composition for coating administration containing epinastine or salt thereof | 参天制药株式会社 | 2023-08-29 | — | — | CN | disclosed |
| EP-0995430-A2 | Use of diacylolycerols for enhancing the barrier function of the skin | Beiersdorf Aktiengesellschaft (DE) | 2000-04-26 | — | — | EP | disclosed |
| EP-0655907-B1 | USE OF DIACYLOLYCEROLS FOR INCREASING THE MELANIN CONTENT IN MELANOCYTES | UNIV BOSTON (US) | 1999-04-28 | — | — | EP | disclosed |
| EP-0295092-B1 | SKIN TREATMENT COMPOSITION | UNILEVER PLC (GB) | 1992-09-23 | — | — | EP | disclosed |
| EP-0295092-A2 | Skin treatment composition | UNILEVER PLC (GB) | 1988-12-14 | — | — | EP | disclosed |